Shin, J., Secora, A., Alexander, G. C., Inker, L. A., Coresh, J., Chang, A. R., & Grams, M. E. (2018). Risks and Benefits of Direct Oral Anticoagulants across the Spectrum of GFR among Incident and Prevalent Patients with Atrial Fibrillation. Clin J Am Soc Nephrol.
Citação norma ChicagoShin, Jung-Im, Alex Secora, G. Caleb Alexander, Lesley A. Inker, Josef Coresh, Alex R. Chang, and Morgan E. Grams. "Risks and Benefits of Direct Oral Anticoagulants Across the Spectrum of GFR Among Incident and Prevalent Patients With Atrial Fibrillation." Clin J Am Soc Nephrol 2018.
Citação norma MLAShin, Jung-Im, et al. "Risks and Benefits of Direct Oral Anticoagulants Across the Spectrum of GFR Among Incident and Prevalent Patients With Atrial Fibrillation." Clin J Am Soc Nephrol 2018.